Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 8.0 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Kite, A Gilead Company.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

2nd Annual Live Medical Crossfire®: Hematologic Malignancies

2nd Annual Live Medical Crossfire®: Hematologic Malignancies


July 14, 2018
Crowne Plaza Times Square Manhattan
1605 Broadway, New York, NY

Overview

Live Medical Crossfire®: Hematologic Malignancies is a live, full-day version of the renowned Medical Crossfire format. This 1-day conference is designed to discuss some of the hottest clinical issues in the management of hematologic malignancies. The meeting is designed to facilitate the practical application of emerging data key to treating various forms of cancer, provide participants with the information they need to inform clinical decision making that allows for personalized approaches, and will ensure participants have the ability to safely apply novel strategies to real-world clinical case scenarios they routinely encounter in their practices.

For the Live Medical Crossfire®, we have assembled renowned experts in the management of leukemias, lymphomas, and myeloma to facilitate the Medical Crossfire. The program format for this meeting is unique. Each tumor’s section will begin with an evidence-based assessment of the evolving therapeutic space and transition quickly to the accompanying clinical questions that will be the focus of the expert crossfire session. Each section will conclude with a crossfire from the live audience at the meeting.

The exciting and innovative format of this meeting promises to provide clinicians with one of the most highly practical and engaging educational forums in medical education today.

Live Medical Crossfire®: Hematologic Malignancies is a unique opportunity for practitioners who manage hematologic malignancies to learn from and interact with leading expert national faculty to build upon their clinical knowledge base, apply new data to practice, and ultimately improve their practices and patient outcomes.

This year's syllabus includes:

  • The latest in clinical data that informs decision-making for your patients with leukemia, lymphoma, and myeloma
  • Expert approaches to differential diagnosis for patients with rare or hard-to-treat disease
  • Novel targeted therapeutic approaches in the front- and second-line
  • Expert perspectives on reducing disparity in care between patients and treatment centers
  • Evolving strategies to address and reduce treatment-related toxicities in your patients

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Kite, A Gilead Company.

Target Audience:

This educational activity is directed toward medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer will be invited to participate.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  • Appraise testing strategies that may inform clinical decision-making in the management of hematologic malignancies
  • Apply clinical trial results to multiple lines of care in the management of hematologic malignancies
  • Analyze disparities in care for patients with hematologic malignancies
  • Outline strategies to monitor and proactively manage treatment-related toxicities in patients with leukemia, lymphoma, and multiple myeloma
  • Identify key emerging data pertaining to the diagnosis and management of patients with hematologic malignancies


Program Co-Chairs

C. Ola Landgren, MD, PhD
Professor of Medicine and Chief of Myeloma Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Martin Tallman, MD
Professor of Medicine and Chief of Leukemia Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY

Anas Younes, MD
Professor of Medicine and Chief of Lymphoma Service
Department of Medicine
Division of Hematologic Oncology
Memorial Sloan Kettering Cancer Center
New York, NY






Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
2728293031
Filter By